Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin for Prevention of Portal Vein Thrombosis After Splenectomy in Cirrhosis
NCT02247414Phase 4Completed
- Sponsor
- Yangzhou University
- Start
- Sep 2014
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of warfarin in portal vein thrombosis (PVT) (2 arms), sponsored by Yangzhou University. Primary endpoint: Proportion of patients with Portal Vein Thrombosis or Spleno-mesenteric Thrombosis at 3 years. Started Sep 2014; status: completed.
02
Drugs
warfarin
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT02247414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02247414.